Global mid-market healthcare mergers and acquisitions (M&A) remained resilient in 2025 with deal value edging up to US$105bn in 2025 from US$103.2bn in 2024. New research from Baker Tilly International, developed in conjunction with Mergermarket, shows while deal volume dipped to 1,037 deals from 1,066, there continues to be competitive appetite for proven healthcare platforms, even as buyers become more disciplined on price, integration risk and regulatory complexity. Healthcare’s overall share of mid-market activity softened slightly. This shift reflects a market where capital is still available but is being deployed more selectively in assets with defensible market positions and clear growth runways.
Read the full article: Mid-Market Healthcare M&A Rebounds as Dealmakers Pursue Fewer, Higher-Conviction Transactions //
Source: https://www.bakertilly.global/news/mid-market-healthcare-m-a-rebounds-as-dealmakers-pursue-fewer-higher-conviction-transactions